Medication related osteonecrosis of the Jaw
Conditions
Interventions
A case-control study will be carried out with a total of 40 participants, 20 in the study group and 20 in the control group. The aim of this study is to identify, quantify and discover the origin of v
SP4.051.512
Sponsors
Universidade de São Paulo - Campus Bauru
Universidade de São Paulo - Campus Bauru
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals over 18 years of age with a confirmed diagnosis of medication; related osteonecrosis of the Jaw according to clinical and imaging criteria according to the American Association of Oral and Maxillofacial Surgeons Annual Meeting; who are being monitored at the Clinical Research Center University of São Paulo Bauru
Exclusion criteria
Exclusion criteria: History of head and neck cancer and undergoing radiotherapy in the head and neck region; current diagnosis of infection in the upper and or lower respiratory tract; gastric reflux; pregnancy; lactation; liver failure; individuals undergoing hemodialysis; individuals with a history of diseases that may pose a risk to themselves or to the evaluator such as sarcoidosis tuberculosis severe heart disease drug or alcohol abuse graft versus host disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify and quantify the origin of volatile sulfur compounds in individuals with Medication-Related Osteonecrosis of the Jaw and associate it with Medication-Related Osteonecrosis of the Jaw staging | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactPaulo Santos
Universidade de São Paulo - Campus Bauru
Outcome results
None listed